文献速递乳房整形与再造

胸肌前双腔组织扩张器置入:能否免用负压引流管?

Prepectoral Dual-Port Tissue Expander Placement: Can This Eliminate Suction Drain Use?
PubMed 文献 · Ann Plast Surg · 2020-01-01

免引流组总体并发症13.7%对20%(P=0.68),手术部位感染7.84%对13.3%(P=0.61),术后6小时疼痛评分3.2对4.3(P=0.03),12小时4.17对5.6(P=0.04)。结论认为双腔扩张器可免引流,感染率低于本机构既往胸肌下扩张器重建报告。

要点

  • 双腔扩张器胸肌前置入可免用负压引流管。
  • 免引流组术后6小时和12小时疼痛评分显著低于引流组。
  • 两组总体并发症和手术部位感染率差异无统计学意义。

核心结论

  • 双腔组织扩张器胸肌前置入可免用负压引流管,感染率7.8%低于本机构既往胸肌下扩张器重建报告(17%和11%)。
  • 总体并发症率与既往乳房切除术后重建数据相似,提示该方案安全且可能减轻引流管相关术后疼痛。

研究设计与样本

  • 回顾性单中心病历 review,纳入2018年1月至2019年6月间所有胸肌前组织扩张器置入患者。
  • 免引流组51个重建使用双腔扩张器且无额外手术引流,引流组15个重建使用标准扩张器加闭合负压引流。

主要发现

  • 免引流组总体并发症13.7%,引流组20%(P=0.68)。
  • 免引流组手术部位感染率7.84%,引流组13.3%(P=0.61)。
  • 免引流组术后6小时平均疼痛数字评分3.2,引流组4.3(P=0.03);12小时分别为4.17和5.6(P=0.04)。
  • 免引流组平均换假体时间152天,引流组126天(P=0.38)。
  • 免引流组中位随访157天,引流组347天。

临床怎么用

  • 对适合胸肌前扩张器重建的患者,可考虑使用双腔扩张器以避免放置负压引流管。
  • 免引流方案可能降低术后早期疼痛评分,但需结合患者个体情况判断。

局限性

  • 免引流组与引流组样本量不平衡(51对15),随访时间不一致(中位157天对347天)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The most common method of performing breast reconstruction after a mastectomy is using tissue expanders. Significant drainage that can lead to seromas and possible infection is a common sequela after mastectomies, and therefore, closed suction drains are routinely placed during the initial surgery (Vardanian et al. Plast Reconstr Surg. 2011;128:403-410). Drains, however, are associated with increased pain and discomfort for the patient and have been attributed to an increased infection rate by some authors (Degnim et al. Ann Surg. 2013;258:240-247; Saratzis et al. Clin Breast Cancer. 2009;9:243-246). We report on our experience using a dual-chamber tissue expander placed in the prepectoral space without acellular dermal matrix or other supportive material, which allows for drainage of periprosthetic fluid and avoids drain placement. PATIENTS AND METHODS: A retrospective, single-institution review of patients' records was performed for all patients who underwent prepectoral tissue expander placement between January 2018 and June 2019. Patients who had drains placed or who underwent autologous reconstruction in combination with expander placement were excluded. Thirty-nine patients were selected, with a total of 66 expander placements. Demographics including body mass index, comorbidities, history of smoking or steroid use, perioperative chemotherapy and radiation therapy, and intraoperative details and indications for surgery were retrospectively collected. Outcomes were separated into minor and major complications. Major complications were defined as complications that required surgical intervention. RESULTS: There were 51 prepectoral reconstructions with a dual-chamber tissue expander and no further surgical drain and 15 reconstructions using a standard expander with an additional closed suction drain. Overall complications for the no-drain cohort were 13.7% compared with 20% in the drain cohort (P = 0.68). Surgical site infection rate is 7.84% in the no-drain cohort compared with 13.3% in the drain cohort (P = 0.61). Mean numeric postoperative pain score at 6 hours was 3.2 in the no-drain cohort compared with 4.3 in the drain cohort (P = 0.03) and 4.17 compared with 5.6 at 12 hours, respectively (P = 0.04). Mean time to exchange of implant in the no-drain cohort was 152 days versus 126 days in the drain cohort (P = 0.38). Median follow-up times were 157 days for the no-drain cohort and 347 days for the drain cohort. CONCLUSIONS: Immediate breast reconstruction using a dual-chamber tissue expander offers a drain-free alternative to the immediate implant-based breast reconstruction. Our infection rate with 7.8% is lower than our own reported rates with subpectoral tissue expander reconstruction using either acellular dermal matrix or poly-4-hydroxybutyrate (17% and 11%). The overall complication rate is similar to historic data associated with breast reconstruction after mastectomy and suggests that dual-chamber expander placement offers a safe alternative possibly decreasing the patient's postoperative pain and discomfort that often is associated with closed suction drains (Saratzis et al. Clin Breast Cancer. 2009;9:243-246).

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Franck P, Chadab T, Poveromo L, et al. Prepectoral Dual-Port Tissue Expander Placement: Can This Eliminate Suction Drain Use? Ann Plast Surg. 2020. PMID: 32530848. doi:10.1097/SAP.0000000000002344

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。